Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке: https://scidar.kg.ac.rs/handle/123456789/8330
Назив: Abo blood group and risk of glioma: A case control study from serbia
Аутори: Arsić A.
Drakulić S.
Vesić, Katarina
Toncev, Gordana
Датум издавања: 2019
Сажетак: © 2019, Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved. Backgraund/Aim. Gliomas are the most common primary brain tumors and the etiology is unknown. The aim of this study was to investigate possible association between incidence in relation to glioma and certain blood groups. Methods. The case-control study included 100 pathologically confirmed cases of glioma at the Clinical centar of Kragujevac, Serbia, between 2014 and 2015, and 200 age- and sex-matched controls without malignant diseases in personal and family history at the same institution. After signing the informed consent, all patients filled out an epidemiological questionnaire. Results. In the analysis comparing the glioma patients with the control group, a significant association (p < 0.0005) was observed in relation to the blood group AB. Furthermore, it was not observed a significant association in relation to the blood group A (p = 0.070), blood group B (p = 0.256), blood group O (p = 0.768) among the compared groups. Also, in the analysis comparing glioma patients with the control group, a significant association was observed in relation to the years spent.
URI: https://scidar.kg.ac.rs/handle/123456789/8330
Тип: article
DOI: 10.2298/VSP161230104A
ISSN: 0042-8450
SCOPUS: 2-s2.0-85069646943
Налази се у колекцијама:Faculty of Medical Sciences, Kragujevac

Број прегледа

454

Број преузимања

12

Датотеке у овој ставци:
Датотека Опис ВеличинаФормат 
10.2298-VSP161230104A.pdf388.1 kBAdobe PDFСличица
Погледајте


Ова ставка је заштићена лиценцом Креативне заједнице Creative Commons